Vol 4, No 3 (2017)
- Year: 2017
- Published: 15.09.2017
- Articles: 14
- URL: https://umo.abvpress.ru/jour/issue/view/13
Full Issue
JUBILEE
Академику Михаилу Ивановичу Давыдову – 70 лет
Abstract
Михаил Иванович Давыдов - блистательный хирург-онколог с мировым именем, известный ученый, профессор, главный внештатный онколог Минздрава России, академик РАМН и РАН, главный онколог медицинского центра Управления делами Президента России, член Европейского и Американского обществ хирургов, Международного общества хирургов и Нью-Йоркской академии наук. По оценкам международных экспертов, он входит в пятерку лучших хирургов мира.
6-7
REVIEW ARTICLES
Chemotherapy: some potential risks under antineoplastic drugs handling
Abstract
There is a large number of healthcare workers who may be exposed to anticancer drugs in different healthcare settings in Russia. Contamination of working environment, throughout the hospital medication system from hospital pharmacy to medical waste facilities, is found in a number of studies. Monitoring of the environmental contamination with these drugs was performed by different methods in various countries. Daily uptake of the anticancer drugs by the personnel exposed for many years may be realized in reproductive impairments and increased cancer risk. The female healthcare workers who handle antineoplastic drugs showed a greater risk of birth defects in offspring, spontaneous abortions, breast cancer and a number of other cancer site revealed by epidemiological methods. Data on the cancer incidence of pharmacists and laboratory workers potentially exposed to the cytostatic drugs are provided. In Russia, the monitoring of occupational cytostatic exposure is required as it would not be correct to apply data obtained in other countries to the Russian conditions. The data for biological and epidemiological monitoring are considered as the background for effective prevention of adverse health effects in healthcare personnel exposed to antineoplastic drugs.
10-20
Metabolic aspects of adoptive immunotherapy of tumors
Abstract
21-26
MicroRNA-155-5p in pathogenesis of cancer
Abstract
27-36
The role of epigenetic factors in the pathogenesis of neurofibromatosis type 1
Abstract
37-49
Secreted protein YB-1 and its prognostic significance
Abstract
50-56
Pharmacogenetic testing of allelic variants of the CYP2D6 gene in hormone positive breast cancer
Abstract
57-66
RESEARCH ARTICLES
The transforming growth factor beta-1 in the oncogenesis of human lung adenocarcinoma
Abstract
Background. The transforming growth factor beta 1 (TGF-β1) is one of the most important tissue factors secreted by the development of epithelial tumors. Increased expression of TGF-β1 in lung tumors promotes cancer cells survival enhancing their growth, migration, invasion, angiogenesis, immune system suppression.
Objective: to study molecular mechanisms of TGF-β1 action on A549 human lung adenocarcinoma cells by means of proteomic high-resolution mass spectrometry. Results. Intracellular signaling pathways responsible for the involvement of TGF-β1 in the oncogenesis of non-small cell lung cancer have been found, which include the differential expressed proteins of the families of cullin, ETS oncogenes, histone diacelases, cyclin-dependent kinases, and the signaling pathway phosphatidylinositol 3-kinase (PI3K).
Conclusions. Important patterns are determined that could be used for the development of new approaches for detection of lung cancer metastasis candidate markers and potential therapy targets of this decease.
67-74
The role of autophagy inhibition in the enhanced cytotoxicity of temozolomide on melanoma cell lines
Abstract
Background. Despite advantages in treatment of metastatic melanoma it remains resistant to current therapy. Recent evidence indicates that tumor cells could overcome death through autophagy, a process that degrades cellular proteins and organelles to maintain cellular biosynthesis during nutrient deprivation or lack of energy. Objective: to investigate the involvement of autophagy inhibitors chloroquine (CQ) and LY-294.002 (LY) in temozolomide (TMZ) cytotoxicity in human melanoma cell lines.
Materials and methods. The study was performed on patient-derived melanoma cell lines Mel Z, Mel IL and Mel MTP. The antiproliferative activity of combined TMZ and autophagy inhibitors treatment was determined by MTT assay and colony-forming assay. Cell cycle analysis, apoptosis activation and expression analysis of key autophagy markers under combined treatment was evaluated.
Results. CQ and LY enhanced the cytotoxicity of TMZ and reduced colony formation in 3 melanoma cell lines, moreover both inhibitors increased cell population in G0 / G1 phase of cell cycle in Mel Z, Mel IL cell lines, but not in Mel MTP. CQ and LY synergistically activated apoptosis in all cell lines. The matrix RNA expression analysis of key autophagy genes showed autophagy involvement in enhanced cytotoxicity.
Conclusions. Thus, autophagy inhibition on different stages of this process could overcome resistance to TMZ and be applicable as potent target in metastatic melanoma treatment.
75-82
Impact of HNF4α disrupted expression on hepatocellular carcinoma cells sensitivity to oncogenic pathways inhibitors
Abstract
Introduction. Hepatocellular carcinoma (HCC) is characterized by aggressive course, high lethality rate and resistance to current systemic treatment. Analysis of molecular aberrations associated with HCC pathogenesis that control biological properties of HCC allows to evaluate potential efficacy of inhibiting certain oncogenic cascades. The present study is focused on investigation of the impact of reduced expression of the key hepatocyte differentiation regulator, HNF4α, often downregulated in HCC, that influences sensitivity of HCC cells to inhibitors of the major oncogenic pathways mTOR, CDK4/6-pRb and ROCK.
Materials and methods. Changes in cells proliferation and migration caused by HNF4А gene stable knockdown were tested in human HCC cell cultures HepG2 and Huh7 followed by examination of these cellular properties under mTOR (rapamycin), CDK4/6 (PD0332991, palbociclib) and ROCK 1/2 (Y27632) inhibitors treatment. Gene expression levels were estimated by the real-time polymerase chain reaction method (Real-Time PCR).
Results. HNF4А gene knockdown alters HepG2 and Huh7 cell migration associated with E-cadherin and N-cadherin expression changes. The HNF4α repression weakens Y27632-induced blockade of HCC cells migration potential. HNF4А gene knockdown causes resistance of Huh7 cells and increase of HepG2 cells sensitivity to rapamycin and PD0332991 that block cells migration ability.
Conclusions. Expression level of HNF4α renders influence on migration of HCC cells and contributes to their sensitivity to mTOR, CDK4/6 and ROCK1/2 inhibitors’ impact on cell migration activity.
83-91
Exosomes and development of cancer cell resistance to metformin: pilot study
Abstract
Objective: to study the role of the intercellular interactions in the progression of the cancer cells resistance to metformin, a biguanide antidiabetic drug exhibited the marked anti-tumor activity.
Results. Earlier we have demonstrated the effect of horizontal transferring of hormonal resistance of breast cancer cells from cell to cell, and showed the key role of exosomes on the transferring of the resistance. Here we have shown the effect of the horizontal transferring of metformin resistance in breast cancer cells – similar to the progression of hormonal resistance. We found that horizontal transferring of the metformin resistance is mediated via exosomes secreted by the resistant cells. The proteome analysis of the exosomes revealed several proteins differentially expressed in the exosomes of metformin-resistant cells and associated with the regulation of cell response to apoptotic drugs.
Conclusions. Totally, the data presented demonstrate the new mechanism of the development of the cancer cell resistance based on the intercellular interactions, opening the new insights in the target therapy of breast cancer.
92-98
Erythrocyte diagnosticum as used in revealingmalignant process
Abstract
99-103
Pancreatic neuroendocrine tumors: new aspects of morphological classification (World Health Organization, 2017)
Abstract
104-108
OBITUARY
109





